Diagnostics(11)
-
Early Detection of Liver Cirrhosis via Algorithmic Screening of EHR Data (No. T4-2392)
Liver cirrhosis often goes undiagnosed until advanced stages, despite being a major global health burden. This technology introduces a machine learning–based algorithm that analyzes routine blood tests from electronic health records (EHR) to predict cirrhosis risk up to five years in advance. ... Read more19219 -
Sparsity Based Non-Contact Vital Signs Monitoring of Multiple People Via Radar (No. T4-2257)
Current contact-based monitoring devices cause patient discomfort, increase infection risks, and demand significant medical staff time. ... Read more18610 -
Nonlinear Waveform Inversion for Quantitative Ultrasound (No. T4-2254)
A Nonlinear Waveform Inversion (NWI) algorithm enhances ultrasound imaging by using Recurrent Neural Networks (RNNs) to reconstruct material properties from acquired signals. ... Read more18751 -
Reusable Gold Nanostars Substrates for Signal Amplification for Diagnostics (No. T4-2127)
Numerous spectroscopic techniques rely on signal enhancement from nanoparticles linked to analyte molecules. However, existing surface-enhanced spectroscopies (SES) typically use nanoparticles dispersed in solution, making them unsuitable for solid substrates. ... Read more12950 -
Covalent Chemistry Platform for Diagnostics and Drug Discovery (No. T4-2045)
CoLDR (Covalent Ligand-Directed Release) chemistry enables site-specific covalent labeling and activation of endogenous proteins using small-molecule covalent ligands. ... Read more6106 -
Cell-free microRNA as a Prognostic Biomarker for Amyotrophic Lateral Sclerosis (ALS) (No. T4-2038)
ALS is a severe neurodegenerative disorder with no cure and highly variable disease progression, which complicates clinical trial design and therapeutic development. ... Read more6115 -
Frontotemporal Dementia Diagnosis Using Circulating microRNA Biomarkers (No. T4-2037)
Frontotemporal dementia (FTD) is difficult to diagnose due to overlapping symptoms with other neurodegenerative disorders, often leading to delays in treatment and clinical trial enrollment. ... Read more6082 -
A Method to Identify Actively Degraded Proteins (No. T4-1832)
MAPP (Mass Spectrometry Analysis of Proteolytic Peptides) is a groundbreaking technology that isolates and identifies proteins actively degraded by the proteasome, offering an unparalleled and direct view of the "active degradome." This innovative approach provides a sensitive an ... Read more6030 -
Microbiome-Based Prediction, Diagnosis, and Treatment of Relapsing Obesity (No. T4-1805)
A novel gut microbiome-based method has been developed to predict and prevent weight regain after weight loss. ... Read more5659 -
Magnetic resonance imaging (MRI) Of Tissue Fibrosis without Contrast Agent (No. T4-1665)
Cardiac fibrosis, a scarring process that impairs cardiac function and increases the risk of sudden death, remains difficult to detect at early stages with current imaging tools. ... Read more5575
Pages
